Look for:

Our offer for

NOVARTIS AG


ISIN:
CH0012005267
WKN:
1200526

2022/09/30 17:31:54
Price
75.53 CHF
Difference 0.81% (0.61)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)171,997 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)75.52 CHF (9,100)
Ask (Ask size)75.53 CHF (6,092)
Open75.08 CHF
High75.91 CHF
Low74.95 CHF
Close (prev. day)74.92 CHF
VWAP75.498781 CHF
Volume (pcs)4,744,495
Trading volume358,203,588.81
Number of trades14,316
Last size151

Futures and Options

Related Futures30
Related Options-

PDF Downloads

Company report: NOVARTIS AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/09/30 17:31:54
Price
75.53 CHF
Difference 0.81% (0.61)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)171,997 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)75.52 CHF (9,100)
Ask (Ask size)75.53 CHF (6,092)
Open75.08 CHF
High75.91 CHF
Low74.95 CHF
Close (prev. day)74.92 CHF
VWAP75.498781 CHF
Volume (pcs)4,744,495
Trading volume358,203,588.81
Number of trades14,316
Last size151

Performance and Risk

6m1Y3Y
Perf (%)-7.33%-1.59%-15.06%
Perf (abs.)-5.97-1.22-13.39
Beta0.690.730.89
Volatility16.8318.3917.92
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)74.73 CHF (5,170,141)
Ø price 30 days | Ø volume 30 days (pcs.)78.07 CHF (4,092,544)
Ø price 100 days | Ø volume 100 days (pcs.)81.50 CHF (3,986,430)
Ø price 250 days | Ø volume 250 days (pcs.)80.35 CHF (4,413,985)
YTD High | date88.42 CHF (2022/05/25)
YTD Low | date72.84 CHF (2022/03/08)
52 Weeks High | date88.42 CHF (2022/05/25)
52 Weeks Low | date72.84 CHF (2022/03/08)

All listings for NOVARTIS AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2019/06/2822:2580.05 EUR1.31125
Stuttgart2019/06/2821:5880.10 EUR0.0411
SIX Swiss Exchange2022/09/3017:3175.53 CHF358.2014,316
London Stock Exchange European Trade Reporting2022/09/3017:3975.53 CHF0.4113
Hanover2019/06/2808:0180.10 EUR0.002
Hamburg2019/06/2814:0580.19 EUR0.084
Frankfurt2019/06/2819:5780.16 EUR0.1313
FINRA other OTC Issues2022/09/2918:0475.766 USD3.299
Duesseldorf2019/06/2814:0880.18 EUR0.002
Berlin2019/06/2818:4580.40 EUR0.0016

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2284&ID_TYPE_IMAGE_LOGO=2

Contact Details

NOVARTIS AG
- -
Lichtstrasse 35 - 4056 Basel
Telefon: 41-61-324-11-11
Fax: 41-61-324-80-01
E-mail: -

PDF Downloads

Company report: NOVARTIS AGPDF Download

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Members of Management Board

Vasant Narasimhan, M.D.Chairman of Managing Board
James E. BradnerMember of Executive Committee
Klaus MoosmayerMember of Executive Committee
Steffen LangMember of Executive Committee
Susanne SchaffertMember of Executive Committee
Harry KirschMember of Executive Committee
John Tsai, M.D.Member of Executive Committee
Karen L. HaleMember of Executive Committee
Marie-France TschudinMember of Executive Committee
Richard SaynorMember of Executive Committee
Rob KowalskiMember of Executive Committee
Robert WeltevredenMember of Executive Committee

Board of directors

Andreas von PlantaMember of the administrative board
Charles SawyersMember of the administrative board
Nancy AndrewsMember of the administrative board
Simon MoroneyMember of the administrative board
Ana de Pro GonzaloMember of the administrative board
Bridgette HellerMember of the administrative board
Daniel HochstrasserMember of the administrative board
Eric BoutinMember of the administrative board
Frans van HoutenMember of the administrative board
Mary DohertyMember of the administrative board
Patrice BulaMember of the administrative board
Ton BüchnerMember of the administrative board
William WintersMember of the administrative board
Hans Jörg ReinhardtChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer